Industry Press Releases

Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Vermillion, South Dakota

Wednesday, Sep 28, 2016
Pressreleases

Biotest Pharmaceuticals Corporation (BPC), a leading manufacturer of immunological biotherapeutic products, is pleased to announce the addition of its second plasma collection center in South Dakota. The 13,800 square foot state-of-the-art facility, located at 1012 Princeton Street in Vermillion, officially opened its doors for business on September 26, 2016.  This location now brings the total number of BPC's plasma collection centers to twenty-one.

"We are excited to open our newest facility in Vermillion. As we strengthen our network of centers, we know we are helping patients worldwide who rely on plasma-based therapies to live healthier and more productive lives. We are fully committed to better serve and meet the needs in this continually expanding industry," said Ileana Carlisle, the Company's Chief Executive Officer.

BPC has invested approximately $1.8 million in the construction of this facility. The Company expects to add over forty jobs to the local economy and currently has employment opportunities available for medical personnel and phlebotomists.

In addition to supporting the local economy through employment opportunities, the Biotest Plasma Center in Vermillion is actively recruiting local residents to become donors.  Plasma donors contribute the source material for these plasma-derived therapies which save the lives of thousands of patients. Donors are compensated for their time spent donating.

About Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals is a wholly-owned subsidiary of Biotest AG, a German global provider of plasma products. The Company researches, develops and manufactures biotherapeutic plasma protein products, with a specialization in immunology and hematology and is a leader in the collection of source plasma. Biotest Pharmaceuticals owns and manages plasmapheresis centers across the United States and operates a state-of-the-art manufacturing facility in Boca Raton, Florida. We are committed to serving the thousands of patients worldwide who rely on plasma-based therapies.

Biotest Pharmaceuticals' team of over 1000 employees is part of Biotest AG's global workforce of more than 2,400 associates worldwide. To learn more about Biotest Pharmaceuticals, our Plasma Centers, and the difference we make in the lives of patients and the healthcare community, please visit us at www.biotestpharma.com and www.biotestplasma.com.

 

Source : prnewswire.com

Other Press Releases